<DOC>
	<DOCNO>NCT02694146</DOCNO>
	<brief_summary>To evaluate efficacy safety platelet rich plasma ( PRP ) patient coxarthrosis donÂ´t respond treatment NSAIDs , compare treatment hyaluronic acid ( Hylan G-F 20 ) .</brief_summary>
	<brief_title>Clinical Trial Evaluate Use Platelet Rich Plasma Front Hyaluronic Acid Coxarthrosis</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis , Hip</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<mesh_term>Hylan</mesh_term>
	<criteria>Patients &gt; 30 year . Patients voluntarily express intention participate inform consent . Diagnosis coxarthrosis fail conservative treatment 6 month Women childbearing potential must negative pregnancy test screening must agree use adequate contraception ( two contraceptive method , one barrier ) participate trial . Treatment infiltration 3 month prior study Prior treatment NSAIDs 24h prior extraction PreSurgical Treatment Hip affect Diabetics Severe liver kidney disease time extraction Thrombocytopenia ( &lt; 100,000 platelet / ml ) baseline Anemia ( Hb 9 &lt; mg / dl ) baseline Hyaluronic acid Allergy History crystal arthropathy , inflammatory arthritis neuropathic arthropathy . Acetabular protrusion History infectious arthritis Excessive deformity ( acetabular dysplasia , Perthes )</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>platelet-rich plasma ( PRP )</keyword>
	<keyword>hyaluronic acid ( Hylan G-F 20 ) .</keyword>
	<keyword>NSAIDs</keyword>
	<keyword>WOMAC</keyword>
</DOC>